These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 20729256)
101. Images in clinical medicine. Baló's concentric sclerosis. Wengert O; Siebert E N Engl J Med; 2011 Aug; 365(8):742. PubMed ID: 21864168 [No Abstract] [Full Text] [Related]
102. A useful annual review of cognition in relapsing MS is beyond most neurologists - Commentary. Hutchinson M Mult Scler; 2016 May; 22(6):730-2. PubMed ID: 27048309 [No Abstract] [Full Text] [Related]
103. The relevance of cortical lesions in patients with multiple sclerosis. Geisseler O; Pflugshaupt T; Bezzola L; Reuter K; Weller D; Schuknecht B; Brugger P; Linnebank M BMC Neurol; 2016 Oct; 16(1):204. PubMed ID: 27769199 [TBL] [Abstract][Full Text] [Related]
104. Ecological impact of isolated cognitive relapses in MS. Meli R; Roccatagliata L; Capello E; Bruschi N; Uccelli A; Mancardi G; Inglese M; Pardini M Mult Scler; 2020 Jan; 26(1):114-117. PubMed ID: 30430928 [TBL] [Abstract][Full Text] [Related]
105. Evaluation of cognitive dysfunction by the clock drawing test in multiple sclerosis and clinically isolated syndrome patients: Correlation with other neuropsychological tests. Tekin S; Bir LS; Oncel C; Unluturk Z; Aydın E Neurosciences (Riyadh); 2022 Oct; 27(4):251-256. PubMed ID: 36252970 [TBL] [Abstract][Full Text] [Related]
108. Significance of the Diagnosis of Executive Functions in Patients with Relapsing-Remitting Multiple Sclerosis. Borkowska AR; Daniluk B; Adamczyk K Int J Environ Res Public Health; 2021 Oct; 18(19):. PubMed ID: 34639827 [TBL] [Abstract][Full Text] [Related]
109. Differentiation of Cognitive Deficit Profiles in Multiple Sclerosis Patients: Latent Profile Analysis. Slavković S; Lazić M; Honan C; Nađ Č; Brkić-Jovanović N; Golubović Š Med Princ Pract; 2019; 28(4):373-379. PubMed ID: 30831571 [TBL] [Abstract][Full Text] [Related]
110. A longitudinal study of cognitive function in multiple sclerosis: is decline inevitable? Katsari M; Kasselimis DS; Giogkaraki E; Breza M; Evangelopoulos ME; Anagnostouli M; Andreadou E; Kilidireas C; Hotary A; Zalonis I; Koutsis G; Potagas C J Neurol; 2020 May; 267(5):1464-1475. PubMed ID: 32008073 [TBL] [Abstract][Full Text] [Related]
111. New MRI lesions and topography at 6 months of treatment initiation and disease activity during follow up in relapsing remitting multiple sclerosis patients. Silveira F; Sánchez F; Miguez J; Contartese L; Gómez A; Patrucco L; Cristiano E; Rojas JI Neurol Res; 2020 Feb; 42(2):148-152. PubMed ID: 31959078 [No Abstract] [Full Text] [Related]
112. A useful annual review of cognition in relapsing MS is beyond most neurologists - NO. Langdon D Mult Scler; 2016 May; 22(6):728-30. PubMed ID: 27048311 [No Abstract] [Full Text] [Related]
113. A useful annual review of cognition in relapsing MS is beyond most neurologists - YES. McNicholas N; McGuigan C Mult Scler; 2016 May; 22(6):726-8. PubMed ID: 27048310 [No Abstract] [Full Text] [Related]
114. Are we ready to define cognitive worsening in MS? How different cutoffs detect future cognitive worsening after six years of follow-up. Damasceno A; Pimentel-Silva LR; Damasceno BP; Cendes F Mult Scler Relat Disord; 2023 Jan; 69():104402. PubMed ID: 36379184 [TBL] [Abstract][Full Text] [Related]